retatrutide type 2 diabetes phase 2 trial 2024 There is a new weight loss shot moving through trials and the numbers are bigger than anything we have seen. It is called Retatrutide. At the highest dose people lost 30 percent The MariTide phase 2 trial

GLP-1 receptor agonists work to lower blood sugar and improve how your body uses insulin

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that has gained recent popularity in its effective management of type 2 diabetes mellitus (T2DM) and obesity

The FDA has approved the first oral GLP-1 for weight loss

Combining metformin with GLP-1 receptor agonists offers complementary metabolic benefits for weight loss and blood sugar control

Allulose might actually improve your health.That's because it stimulates your body's production of GLP-1, which should sound familiar beca

One study showed that there were 1 million new GLP-1 receptor agonists users from 2011 to